Provision of Laboratory Services to Support the Delivery of the HPV Primary Screening Pathway within the NHS Cervical Screening Programme - West Midlands

Location

Birmingham

Description

The aim of the NHS CSP is to reduce the incidence of, and mortality from, cervical cancer by delivering a systematic quality assured population-based screening programme for eligible people. The aim of the Service is to support the delivery of the NHS CSP by testing samples and making direct referrals to colposcopy.

Total Quantity or Scope

The relevant authority intends to award a contract to an existing provider under Direct Award C under the Health Care Services (Provider Selection Regime) regulations 2023. The final contract value is still to be finalised as it is dependent on the national NHS planning guidance which is still to be released. The contract value is £20,050,605. Contract Start Date: 01 July 2026 Contract End Date: 31 March 2029 The contract term is for an initial period of 21 months, with an option to extend for a further 12 months at the discretion of the Relevant Authority and subject to satisfactory contractual and financial performance.

Award Detail

Award Criteria

CPV Codes

• 85145000 - Services provided by medical laboratories
• 85100000 - Health services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by midnight on Friday 30th January 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. A contract will not be awarded until after the 9th working day following standstill.

Other Information

£20,050,605 based on 21 months (plus annual population growth 0.7%, 1.25% fixed payment and national inflation/CUF); +1 year extension TBC if enacted (noting final activity modelling for extension is to be agreed due to impact of programme change/extended screening intervals as yet unknown) This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by midnight on Friday 30th January 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. A contract will not be awarded until after the 9th working day following standstill. Written representation should be sent to: Necsu.psrprocurement@nhs.net Details of the individuals/group making the award decision: Senior Commissioning Manager - NHS England Contracts Manager - NHS England Senior Commissioning Manager - NHS England Midlands SGG (Screening Governance Group) and RCG (Regional Commissioning Group) The existing provider is satisfying the existing contract and will likely satisfy the proposed new contract. The provider has been assessed and passed against the relevant 5 key criteria and mandatory requirements. There were no conflicts of interests identified.